SCHEMBL29638535

SCHEMBL29638535

Cc1ccc2c(Nc3cc(F)c(F)cc3F)nccc2c1NC(=O)c1cccc2c(N)ncnc12

nearest known ligand 0.60

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
BRAF P15056 15/20 0.60
RAF1 P04049 12/20 0.60
CSF1R P07333 5/20 0.60
DDR1 Q08345 5/20 0.60
DDR2 Q16832 5/20 0.60
ARAF P10398 1/20 0.60
ERN1 O75460 3/20 0.45
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
KDR P35968 1/20 0.39
LMNA P02545 1/20 0.37
ESR1 P03372 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25375879 1.00 BRAF (0.60) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638562 0.92 BRAF (0.58) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638656 0.92 BRAF (0.58) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL25375935 0.92 BRAF (0.58) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL25374806 0.92 BRAF (0.58) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL24399643 0.92 BRAF (0.60) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638560 0.92 BRAF (0.58) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL25376864 0.92 BRAF (0.58) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL30402337 0.92 BRAF (0.60) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL24399765 0.91 BRAF (0.61) BRAFRAF1CSF1RDDR1DDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096718-A Aryl amide compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-05-09 CN disclosed
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 WO disclosed